Type 2 Diabetes
Conditions
Keywords
Foot massage, Reflexology, Neuropatic pain, Nursing, neuropathy
Brief summary
This study is conducted to measure the effect of foot reflexology massage on neuropathic pain in diabetic patients.Is reflexology foot massage applied to type 2 diabetic patients effective on neuropathic pain?
Detailed description
Controlling pain in individuals with diabetes; It is important for the individual to relax, increase the quality of life, reduce complications and shorten the duration of hospital stay. For this reason, the importance of neuropathic pain and its treatment is increasing in terms of public health. In this study, the effect of foot reflexology massage applied to women with type 2 diabetes on neuropathic pain was measured.
Interventions
Reflexology Massage
Sponsors
University of Gaziantep
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Masking description
experimental and control group
Intervention model description
At this stage, the patients in the intervention group received a foot reflexology massage by the researcher in the podiatry room of the Endocrinology and Metabolic Diseases polyclinic in a quiet and calm environment for 6 weeks, two sessions per week, for a total of 12 sessions and 30-40 minutes (15-20 minutes for each foot). Data collection forms were filled out for the patients in the control group, but no application was made.
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
1. Those diagnosed with type 2 diabetes, 2. Being 18 years or older 3. Individuals who do not have any fractures in the extremities, skin diseases, past wound history, open wounds and unilateral or bilateral amputation, tendonitis in the ankle, active foot ulcer and infection. 4. Those who volunteer to participate in the study, 5. Those who do not have problems with verbal communication, 6. Those who have not been diagnosed with any psychiatric disease. 7. Those with neuropathic pain of 12 points and above according to the LANS score 8. Patients receiving duloxetine drug therapy 9. Those who are not pregnant 10. Patients without peripheral artery disease, deep vein thrombosis and gonatosis will be included in the study. -
Exclusion criteria
1. Those who did not agree to participate in the study 2. Those under 18 years of age 3. Individuals with no fractures in the extremities, skin diseases, past wound history, open wounds and unilateral or bilateral amputation, tendonitis in the ankle, active foot ulcers and infections. 4. Those who have problems with verbal communication 5. Those with neuropathic pain below 12 points according to the LANS score 6. Patients receiving treatment other than duloxetine drug therapy 7. Those who are pregnant 8. Those with any psychiatric disorder 9. Patients with peripheral artery disease, deep vein thrombosis and gonatosis will not be included in the study.-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| pain score | 6 Weeks | visual analog scale:VAS: It is a scale scored between 0 and 10 points. A score of 0 indicates that the patient has no pain, and a score of 10 indicates that the patient has unbearable pain. The patient gives a score between 0 and 10 depending on the pain condition. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Four Question Neuropathic Pain Questionnaire | 6 weeks | This questionnaire consists of a total of 10 items; 7 items are related to the quality of pain (burning, painful cold, electric shocks) and its relationship with abnormal sensations (tingling, pins and needles, numbness, itching), and 3 items are related to the clinical examination of the painful area (touch hypoesthesia, pricking hypoesthesia, tactile allodynia). Each item is scored 1 if the answer is yes and zero if no, with a minimum of zero and a maximum of 10 points. In this assessment, a score of ≥4 out of 10 is considered neuropathic pain |
Countries
Turkey (Türkiye)
Outcome results
None listed